The trademark application BEXIGNUS was filed by Faron Pharmaceuticals Oy, a corporation established under the laws of the Republic of Finland (the "Applicant"). The application was published for oppositions on March 14, 2022, and it was registered by office on June 21, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1684033 at the World Intellectual Property Organization (WIPO).
The application was filed in Finnish (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Medical preparations
Veterinary preparations
Sanitary preparations for medical purposes
Pharmaceutical preparations and substances for the treatment of cancer
Tumor suppressing agents
Antineoplastics
Anti-cancer preparations
Compounds for treating cancer
Antibodies
Biological preparations for medical purposes
Adjuvants for medical purposes
Vaccine adjuvants
Anti-neoplastic preparations of chemical origin
Anti-neoplastic preparations of microbial origin
Antigens
Biological preparations for the treatment of cancer
Biopharmaceuticals for the treatment of cancer
Biotechnological preparations for medical use
Immunomodulators
Pharmaceutical preparations for the treatment of immune system related diseases and disorders
Pharmaceutical preparations and substances for use in oncology
Pharmaceutical preparations for the prevention of disorders of the immune system
Serotherapeutic medicines
Pharmaceutical preparations for immunity adjustment
Pharmaceutical preparations for regulating the immune system
Pharmaceutical preparations for the treatment of autoimmune diseases
Pharmaceutical preparations for use in hematology.